Alicia C. Olivo - Aug 1, 2023 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role: General Counsel
Signature: /s/ Alicia C. Olivo
Stock symbol: NEO
Transactions as of: Aug 1, 2023
Transactions value $: $0
Form type: 4
Date filed: 8/1/2023, 05:26 PM
Previous filing: May 15, 2023
Next filing: Sep 5, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NEO	Common Stock	Tax liability	$0	-14	-0.03%	$0.00	41K	Aug 1, 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NEO	Stock Option (Right to Buy)						1.05K	Aug 1, 2023	Common Stock	1.05K	$19.12	Direct	F3
holding	NEO	Stock Option (Right to Buy)						1.02K	Aug 1, 2023	Common Stock	1.02K	$27.34	Direct	F4
holding	NEO	Stock Option (Right to Buy)						516	Aug 1, 2023	Common Stock	516	$48.99	Direct	F5
holding	NEO	Stock Option (Right to Buy)						1.12K	Aug 1, 2023	Common Stock	1.12K	$46.10	Direct	F6
holding	NEO	Stock Option (Right to Buy)						22.2K	Aug 1, 2023	Common Stock	22.2K	$9.45	Direct	F7
holding	NEO	Stock Option (Right to Buy)						55.3K	Aug 1, 2023	Common Stock	55.3K	$10.05	Direct	F8
holding	NEO	Stock Option (Right to Buy)						36.5K	Aug 1, 2023	Common Stock	36.5K	$19.65	Direct	F9
holding	NEO	Restricted Stock Unit						19.5K	Aug 1, 2023	Common Stock	19.5K	$0.00	Direct	F10, F11
holding	NEO	Performance Stock Unit						19.5K	Aug 1, 2023	Common Stock	19.5K	$0.00	Direct	F11, F12

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the August 1, 2023 vesting of restricted stock.
F2	This balance includes 301 shares that were acquired pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) since the date of the reporting person's last filing. The shares were acquired in transactions exempt from Section 16b-3.
F3	On September 30, 2019, Ms. Olivo was granted 1,394 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F4	On May 1, 2020, Ms. Olivo was granted 1,024 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F5	On May 1, 2021, Ms. Olivo was granted 516 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F6	On August 1, 2021, Ms. Olivo was granted 1,117 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F7	On May 1, 2022, Ms. Olivo was granted 22,222 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F8	On September 1, 2022, Ms. Olivo was granted 55,332 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F9	On May 11, 2023, Ms. Olivo was granted 36,508 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F10	On May 11, 2023, Ms. Olivo was granted 19,508 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F11	Once vested, the shares of common stock are not subject to expiration.
F12	On May 11, 2023, Ms. Olivo was granted 19,508 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 29,262. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.